A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis C Antibody
Test CodeAlias/See Also
CPT Codes
86803
Preferred Specimen
Serum (gold top tube)
Minimum Volume
Other Acceptable Specimens
Transport Container
Serum (gold top) or Lithium Heparin (green top) Tube
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Chemiluminescence
Setup Schedule
Daily upon receipt
Report Available
Limitations
Reference Range
Interpretation:
Negative: Anti-HCV IgG antibody is not detected. Patient is presumed not to be infected with HCV. A negative test result does not exclude the possibility of exposure to or infection with HCV. HCV antibodies may be undetectable in some stages of the infection and in some clinical conditions. Follow CDC recommendations for supplemental testing of reactive samples. A negative test does not rule out other types of viral hepatitis
Equivocal: Concentration of Hepatitis C Antibodies is greater than the cutoff for a "Negative" result but less than the cutoff for a "Positive" result.
Positive: Anti-HCV IgG antibody is detected. Patient is presumed to be infected with HCV, state or associated disease not determined. Follow CBC recommendations for supplemental testing.
Clinical Significance
The hepatitis C virus (HCV) is now known to be the causative agent for most, if not all, blood-borne non-A, non-B hepatitis (NANBH). Studies throughout the world indicate that HCV is transmitted through contaminated blood and blood products, through blood transfusions or through other close, personal contacts. The presence of anti-HCV indicates that an individual may have been infected with HCV and may be capable of transmitting HCV infection.